Home » Newsletters » BioWorld

BioWorld

Sep. 24, 2009

View Archived Issues

Nexavar Continues to Wow in Breast Cancer Combo Study

The data just keep getting better for Nexavar in breast cancer. (BioWorld Today) Read More

No-Vote Panel: Exalgo Approval Needs Tight Abuse Safeguards

Direct RNA Sequencing May Get at 'True Transcriptome' of Cell

Pair of Phase III Trials Upcoming, Spectrum Adds $50M to Coffers

DxS Acquisition Boosts Qiagen's Companion Diagnostics Portfolio

Clinic Roundup

Appointments And Advancements

Other News To Note